637
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Purification of bovine serum paraoxonase and its immobilization on Eupergit C 250 L by covalent attachment

&
Pages 69-74 | Received 05 Dec 2013, Accepted 16 Dec 2013, Published online: 31 Mar 2014

References

  • La Du BN, Aviram M, Billecke S, et al. On the physiological role(s) of the paraoxonase. Chem Biol Interact 1999;119-120:379–88
  • Hassett C, Richter RJ, Humbert R, et al. Characterisation of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 1991;30:10141–9
  • Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100–6
  • Sinan S, Kockar F, Arslan O. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics. Biochimie 2006;88:565–74
  • Aldridge WN. Serum esterases 2. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E 600) and its identity with the A-esterase of mammalian sera. J Biochem 1995;53:117–24
  • Draganov D, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004;369:78–88
  • Mackness B, Durrington PN, Boulton AJ, et al. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 2002;32:259–64
  • Turk R, Juretić D, Gereš D, et al. Flegar–Meštrić influence of oxidative stress and metabolic adaptation on PON1 activity and MDA level in transition dairy cows. Anim Reprod Sci 2008;108:98–106
  • Kitchen BJ, Masters CJ, Winzor DJ. Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase. Biochem J 1973;135:93–9
  • Don MM, Masters CJ, Winzor DJ. Further evidence for the concept of bovine plasma arylesterase as a lipoprotein. Biochem J 1975;151:625–30
  • Turk R, Juretic D, Geres D, et al. Serum paraoxonase activity in dairy cows during pregnancy. Res Veter Sci 2005;79:15–18
  • Jones TT, Fernandez EJ. Hydrophobic interaction chromatography selectivity changes among three stable proteins: conformation does not play a major role. Biotechnol Bioeng 2004;87:388–99
  • Katchalski-Katzir E. Immobilized enzymes-learning from past successes and failures. Trends Biotechnol 1993;11:471–8
  • Kennedy JF, Melo EHM, Jumel K. Immobilized enzymes and cells. Chem Eng Prog 1990;45:81–9
  • Giacomini C, Irazoqui G, Batista-Viera F, Brena BM. Influence of the immobilization chemistry on the properties of immobilized β-galactosidases. J Mol Catal B Enzym 2001;11:597–606
  • Mateo C, Abian O, Fernandez R, Guisan JM. Increase in conformational stability of enzymes immobilized on epoxy-activated supports by favoring additional multipoint covalent attachment. Enzyme Microb Technol 2000;26:509–15
  • Bes T, Gomez-Moreno C, Guisan JM, Fernandez-Lafuente R. Selective enzymatic oxidations: stabilization by multipoint covalent attachment of ferredoxin NAD-reductase: an interesting cofactor recycling enzyme. J Mol Catal 1995;98:161–9
  • Fernandez-Lafuente R, Rodriguez V, Guisan JM. The coimmobilization of D-amino acid oxidase and catalase enables the quantitative transformation of D-amino acids (D-phenylalanine) into keto acids (phenylpyruvic acid). Enzyme Microb Technol 1998;23:28–33
  • Gupta MN. Thermostabilization of proteins. Biotechnol Appl Biochem 1991;14:1–11
  • Nanalov RJ, Kamboure MS, Emanuiloda EI. Immobilization and properties of Bacillus stearothermophilus pulanase. Biotechnol Appl Biochem 1993;18:409–16
  • Desmukth SS, Duta M, Choudohury S, Shanker V. Preparation and properties of glucose isomerase immobilized on indon 48-R. Appl Biochem Biotechnol 1993;42:95–104
  • Brackley M, Carro-Ciampi G, Stewart DJ, et al. Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage times. Res Commun Chem Pathol Pharmacol 1983;41:65–78
  • Bradford MM. A rapid and sensitive method for the quantition of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–51
  • Laemmli UK. Cleavage of structual proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685
  • Adler A, Disteche CM, Omiecinski CJ, et al. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem Biol Interact 1993;87:35–48
  • Rodrigo L, Gil F, Hernandez AH, et al. Purification and characterization of paraoxon hydrolyse from rat liver. Biochem J 1997;321:595–601
  • Furlong CE, Costa LG, Hasett C, et al. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem Biol İnteract 1993;87:35–48
  • Beltowski J, Wojcicka G, Jamroz A. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) or tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities. J Cardiovasc Pharmacol 2004;43:121–7
  • Main AR. The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion. Can J Biochem Physiol 1956;34:197–216
  • Rodrigo L, Gil F, Hernandez AF, et al. Purification and characterization of paraoxon hydrolyse from Rat Liver. J Biochem 1997;321:595–601
  • Furlong CE, Richter RJ, Chapline C, Crabb JW. Purification of rabbit and human serum paraoxonase. Biochemistry 1991;30:10133–40
  • Blatter-Garin MC, Kalix B, De Pre S, James RW. Aspirin use is associated with higher serum concentrations of the antioxidant enzyme, paraoxonase-1. Diabetologia 2003;46:593–4
  • Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 2005;15:261–7
  • Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radic Biol Med 2005;37:1317–23
  • Khateeb J, Gantman A, Kreitenberg AJ, et al. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis 2010;8:119–25
  • Supuran CT. Carbonic anhydrases as drug targets – an overview. Curr Top Med Chem 2007;7:825–33
  • Gupte SA. Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases. Curr Opin Investig Drugs 2008;9:993–1000
  • Akkemik E, Budak H, Ciftci M. Effects of some drugs on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro study. J Enzyme Inhib Med Chem 2010;25:476–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.